Diabetes & Obesity Therapeutic Area (DOTA) is engaged in accelerating the path of novel diabetes and obesity therapies for clinical development within Novo Nordisk. A main focus is discovery and evaluation of novel targets that can modulate cardiometabolic disease and advance the projects to deliver to the NN pipeline. The therapeutic area (TA) teams collaborate closely with the teams in R&D (Research & Development) in Novo Nordisk sites around the globe. The TA will drive a high level of scientific innovation in the scientific and therapy area of diabetes % obesity to assure the key and most important scientific topics and areas are being pursued to support Novo Nordisk's pipeline aspirations. The Scientific Director Biology Integration actualizes Novo Nordisk's externalization agenda by driving pipeline impact from alliances, research collaborations and business development activities in Diabetes & Obesity. The position contributes to our drug pipeline by using comprehensive knowledge of early drug discovery and development, R&D's strategic priorities, and external collaborations. In addition, the Scientific or will use their expertise to determine the most impactful areas in which external collaborations can be used to develop novel insights to enhance the early project portfolio or accelerate our path to project maturation. This position is an independent contributor and will initiate collaborations and establish high-impact partnerships fully independently.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Education Level
Ph.D. or professional degree
Number of Employees
5,001-10,000 employees